Budaj, Andrzej
Grochowski Hospital
16 papers on CoChatORCID 0000-0002-6395-2098
Most cited papers
- Verified
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet
Cardiovascular Health and Risk FactorsAcute Myocardial Infarction Research
Cited by 12,026
- Verified
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
Wallentin, L., Becker, R. C., Budaj, A., Cannon, C. P., Emanuelsson, H., Held, C., Horrow, J., Husted, S., James, S., Katus, H., et al. (2009) · New England Journal of Medicine
Antiplatelet Therapy and Cardiovascular DiseasesAcute Myocardial Infarction Research
Cited by 7,117
- Verified
2013 ESC guidelines on the management of stable coronary artery disease
Task Force Members, Montalescot, G., Sechtem, U., Achenbach, S., Andreotti, F., Arden, C., Budaj, A., Bugiardini, R., Crea, F., Cuisset, T., et al. (2013) · European Heart Journal
Clinical practice guidelines implementationCoronary Interventions and Diagnostics
Cited by 4,510
- Verified
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation
Atrial Fibrillation Management and OutcomesClinical practice guidelines implementation
Cited by 2,805
- Verified
Apixaban in patients with atrial fibrillation
Connolly, S. J., Eikelboom, J., Joyner, C., Diener, H.-C., Hart, R., Golitsyn, S., Flaker, G., Avezum, A., Hohnloser, S. H., Diaz, R., et al. (2011) · New England Journal of Medicine
Atrial Fibrillation Management and OutcomesVenous Thromboembolism Diagnosis and Management
Cited by 2,483
- Verified
Long-term use of ticagrelor in patients with prior myocardial infarction
Bonaca, M. P., Bhatt, D. L., Cohen, M., Steg, P. G., Storey, R. F., Jensen, E. C., Magnani, G., Bansilal, S., Fish, M. P., Im, K., et al. (2015) · New England Journal of Medicine
Antiplatelet Therapy and Cardiovascular DiseasesAcute Myocardial Infarction Research
Cited by 1,999
- Verified
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
Ridker, P. M., MacFadyen, J. G., Thuren, T., Everett, B. M., Libby, P., Glynn, R. J., Ridker, P., Lorenzatti, A., Krum, H., Varigos, J., et al. (2017) · The Lancet
Inflammasome and immune disordersInflammatory Biomarkers in Disease Prognosis
Cited by 1,344
- Verified
Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation
Lopes, R. D., Heizer, G., Aronson, R., Vora, A. N., Massaro, T., Mehran, R., Goodman, S. G., Windecker, S., Darius, H., Li, J., et al. (2019) · New England Journal of Medicine
Atrial Fibrillation Management and OutcomesAntiplatelet Therapy and Cardiovascular Diseases
Cited by 1,228
- Verified · note
Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: Insights From the DECLARE-TIMI 58 Trial
Zelniker, T. A., Bonaca, M. P., Furtado, R. H. M., Mosenzon, O., Kuder, J. F., Murphy, S. A., Bhatt, D. L., Leiter, L. A., McGuire, D. K., Wilding, J. P. H., et al. (2020) · Circulation
Diabetes Treatment and ManagementAtrial Fibrillation Management and Outcomes
Cited by 459
- Verified
Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients
Bohula, E. A., Wiviott, S. D., McGuire, D. K., Inzucchi, S. E., Kuder, J., Im, K., Fanola, C. L., Qamar, A., Brown, C., Budaj, A., et al. (2018) · New England Journal of Medicine
Pharmacology and Obesity TreatmentDiabetes Treatment and Management
Cited by 265
- Verified
Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction: A Randomized Clinical Trial
O’Donoghue, M. L., Glaser, R., Cavender, M. A., Aylward, P. E., Bonaca, M. P., Budaj, A., Davies, R. Y., Dellborg, M., Fox, K. A. A., Gutierrez, J. A. T., et al. (2016) · JAMA
Acute Myocardial Infarction ResearchCardiac Fibrosis and Remodeling
Cited by 249
- Verified
Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial
Bohula, E. A., Scirica, B. M., Inzucchi, S. E., McGuire, D. K., Keech, A. C., Smith, S. R., Kanevsky, E., Murphy, S. A., Leiter, L. A., Dwyer, J. P., et al. (2018) · The Lancet
Pharmacology and Obesity TreatmentDiabetes Treatment and Management
Cited by 94
- Verified
Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin: The Apixaban Versus Acetylsalicylic Acid to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin k Antagonist Treatment (AVERROES) Trial
Flaker, G. C., Eikelboom, J. W., Shestakovska, O., Connolly, S. J., Kaatz, S., Budaj, A., Husted, S., Yusuf, S., Lip, G. Y. H., & Hart, R. G. (2012) · Stroke
Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke Management
Cited by 94
- Verified
Healthy eating and reduced risk of cognitive decline: A cohort from 40 countries
Smyth, A., Dehghan, M., O'Donnell, M., Anderson, C., Teo, K., Gao, P., Sleight, P., Dagenais, G., Probstfield, J. L., Mente, A., et al. (2015) · Neurology
Nutritional Studies and DietDementia and Cognitive Impairment Research
Cited by 85
- Verified
Screening for glucose perturbations and risk factor management in dysglycemic patients with coronary artery disease—a persistent challenge in need of substantial improvement: a report from ESC EORP EUROASPIRE V
Ferrannini, G., De Bacquer, D., De Backer, G., Kotseva, K., Mellbin, L., Wood, D., Rydén, L., collaborators, E. V., Gale, C. P., Beleslin, B., et al. (2020) · Diabetes Care
Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management
Cited by 75
- Verified
Glucose levels compared with diabetes history in the risk assessment of patients with acute myocardial infarction
Goyal, A., Mehta, S. R., Gerstein, H. C., Díaz, R., Afzal, R., Xavier, D., Zhu, J., Pais, P., Lisheng, L., Kazmi, K. A., et al. (2009) · American Heart Journal
Acute Myocardial Infarction ResearchHyperglycemia and glycemic control in critically ill and hospitalized patients
Cited by 35
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free